Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

PLEUR-EVAC PLUS CONTIN. REINFUS. & AUTOINFUS. SYST

K-Number: K911656 · 1991-08-13

ApplicantPfizer Hospital Products Group, Inc.
Decision Date1991-08-13
Product CodeCAC
Advisory CommitteeAN
DecisionSubstantially Equivalent

Device Summary

PLEUR-EVAC PLUS CONTIN. REINFUS. & AUTOINFUS. SYST is the device name listed in this FDA 510(k) record. The listed applicant is Pfizer Hospital Products Group, Inc.. It received FDA 510(k) clearance on 1991-08-13 under 510(k) number K911656. The device is classified under product code CAC. It was reviewed by the AN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the PLEUR-EVAC PLUS CONTIN. REINFUS. & AUTOINFUS. SYST?

PLEUR-EVAC PLUS CONTIN. REINFUS. & AUTOINFUS. SYST is a medical device that received FDA 510(k) clearance on 1991-08-13. The listed applicant is Pfizer Hospital Products Group, Inc.. The 510(k) number is K911656.

When did PLEUR-EVAC PLUS CONTIN. REINFUS. & AUTOINFUS. SYST receive FDA 510(k) clearance?

PLEUR-EVAC PLUS CONTIN. REINFUS. & AUTOINFUS. SYST received FDA 510(k) clearance on 1991-08-13, under 510(k) number K911656.

Who is the listed applicant for PLEUR-EVAC PLUS CONTIN. REINFUS. & AUTOINFUS. SYST?

The FDA 510(k) record lists Pfizer Hospital Products Group, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for PLEUR-EVAC PLUS CONTIN. REINFUS. & AUTOINFUS. SYST?

The FDA product code for PLEUR-EVAC PLUS CONTIN. REINFUS. & AUTOINFUS. SYST is CAC.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Pfizer Hospital Products Group, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K930156MEGA PLUS SUPER LAG SCREWK915512DURACON TOTAL KNEE SYSTEM TIBIAL COMPONENTSK920831PCA TOTAL HIP SYSTEM (CEMENTLESS USE)K920034DURACON MODULAR FEMORAL COMPONENT AND FEMORAL SPACK915184HOWMEDICA ALUMINA FEMORAL HEADK911292SCHNEIDER WALLSTENT(R)

View all 8 devices →

Related Devices (Code: CAC)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K241236XTRA Collection sets; XTRA Sequestration set XSorin Group Italia S.R.L.K240426Aventus Clot Management SystemInquis MedicalK240584XTRA Autotransfusion System (with XTRA Bowl sets)Sorin Group Italia S.R.L.K231782FlowSaver Blood Return System (80-101)Inari Medical, Inc.K221483FlowSaver Blood Return SystemInari Medical, Inc.K221722Haemonetics Cell Saver Elite/Elite+ Autotransfusion System (CSE-E-US/CSE-EW-US)Haemonetics Corporation

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑